Induction of Interleukin-22 (IL-22) production in CD4+ T Cells by IL-17A Secreted from CpG-Stimulated Keratinocytes
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Interleukin-17A (IL-17A) is mainly secreted from Th17 cells that are activated by various stimuli including CpG oligodeoxynucleotide, a Toll-like receptor 9 (TLR9) ligand. Recently, it has been demonstrated that keratinocytes play an important role in the pathogenesis of psoriasis. Objective: To investigate the potential role of keratinocytes, we examined whether TLR9 ligand CpG induces IL-17A expression in keratinocytes. Methods: We used HaCaT keratinocytes as a model system, and determined CpG-induced IL-17A using enzyme-linked immunosorbent assay and Western blot. Results: When HaCaT keratinocytes were treated with CpG, the expression of several cytokines including IL-17A, tumor necrosis factor-α and CCL20 was markedly increased. Treatment with nuclear factor (NF)-κB inhibitor significantly blocked the CpG-induced IL-17A production, indicating that CpG induced IL-17A expression through the NF-κB signaling pathway. In addition, IL-17A secreted from keratinocytes stimulated the CD4+ T cells, resulting in strong induction of IL-22 production. Conclusion: Since IL-22 is an important mediator for psoriatic inflammation, our data suggest that keratinocytes can participate in the pathogenesis of psoriasis via the TLR9-dependent IL-17A production.
Abstract
Background: Interleukin-17A (IL-17A) is mainly secreted from Th17 cells that are activated by various stimuli including CpG oligodeoxynucleotide, a Toll-like receptor 9 (TLR9) ligand. Recently, it has been demonstrated that keratinocytes play an important role in the pathogenesis of psoriasis. Objective: To investigate the potential role of keratinocytes, we examined whether TLR9 ligand CpG induces IL-17A expression in keratinocytes. Methods: We used HaCaT keratinocytes as a model system, and determined CpG-induced IL-17A using enzyme-linked immunosorbent assay and Western blot. Results: When HaCaT keratinocytes were treated with CpG, the expression of several cytokines including IL-17A, tumor necrosis factor-α and CCL20 was markedly increased. Treatment with nuclear factor (NF)-κB inhibitor significantly blocked the CpG-induced IL-17A production, indicating that CpG induced IL-17A expression through the NF-κB signaling pathway. In addition, IL-17A secreted from keratinocytes stimulated the CD4+ T cells, resulting in strong induction of IL-22 production. Conclusion: Since IL-22 is an important mediator for psoriatic inflammation, our data suggest that keratinocytes can participate in the pathogenesis of psoriasis via the TLR9-dependent IL-17A production.
참고문헌 (32)
- Li Y., "Unraveling the genetics of complex diseases : susceptibility genes for rheumatoid arthritis and psoriasis", Semin Immunol, 21, pp.318~327 (2009)
- Nakajima H., "Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients", Arch Dermatol Res, 303, pp.451~455 (2011)
- Becher B., "Hiding under the skin : interleukin-17-producing γδ T cells go under the skin?", Nat Med, 18, pp.1748~1750 (2012)
- Pappu R., "Regulation of epithelial immunity by IL-17 family cytokines", Trends Immunol, 33, pp.343~349 (2012)
- Iwakura Y., "The roles of IL-17A in inflammatory immune responses and host defense against pathogens", Immunol Rev, 226, pp.57~79 (2008)
- Truchetet ME., "IL-17 in the rheumatologist's line of sight", Biomed Res Int (2013)[DOI]
- Iwakura Y., "Functional specialization of interleukin-17 family members", Immunity, 34, pp.149~162 (2011)
- Zhang L., "Increased Th17 cells are accompanied by FoxP3(+)Treg cell accumulation and correlated with psoriasis disease severity", Clin Immunol, 135, pp.108~117 (2010)
- Rich P., "Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis : a randomized, double-blind, placebo-controlled, phase II regimen-finding study", Br J Dermatol, 168, pp.402~411 (2013)
- Trinchieri G., "Cooperation of Toll-like receptor signals in innate immune defence", Nat Rev Immunol, 7, pp.179~190 (2007)
- Medzhitov R, "Toll-like receptors and innate immunity", Nat Rev Immunol, 1, pp.135~145 (2001)
- Iwasaki A., "Toll-like receptor control of the adaptive immune responses", Nat Immunol, 5, pp.987~995 (2004)
- McInturff JE., "The role of toll-like receptors in the pathogenesis and treatment of dermatological disease", J Invest Dermatol, 125, pp.1~8 (2005)
- Kawai K, "Expression of functional toll-like receptors on cultured human epidermal keratinocytes", J Invest Dermatol, 121, pp.217~ (2003)
- Miller LS., "TGF-alpha regulates TLR expression and function on epidermal keratinocytes", J Immunol, 174, pp.6137~6143 (2005)
- Li ZJ., "Roles of TLR7 in activation of NF-κB signaling of keratinocytes by imiquimod", PLoS One, 8, pp.e77159~ (2013)
- Köllisch G., "Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes", Immunology, 114, pp.531~541 (2005)
- Lebre MC., "Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9", J Invest Dermatol, 127, pp.331~341 (2007)
- Res PC., "Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis", PLoS One, 5 (2010)
- Garber K., "Genetics: deep exploration", Nature, 492, pp.S56~S57 (2012)
- Balato A., "IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation", Exp Dermatol, 21, pp.892~894 (2012)
- Gutowska-Owsiak D., "The epidermis as an adjuvant", J Invest Dermatol, 132, pp.940~948 (2012)
- Miller LS., "Toll-like receptors in the skin", Semin Immunopathol, 29, pp.15~26 (2007)
- Terhorst D., "The role of toll-like receptors in host defenses and their relevance to dermatologic diseases", Am J Clin Dermatol, 11, pp.1~10 (2010)
- Mogensen TH, "Pathogen recognition and inflammatory signaling in innate immune defenses", Clin Microbiol Rev, 22, pp.240~273 (2009)
- Oeckinghaus A., "Crosstalk in NF-κB signaling pathways", Nat Immunol, 12, pp.695~708 (2011)
- 정미숙, "Calcitriol May Down-Regulate mRNA Over-Expression of Toll-Like Receptor-2 and -4, LL-37 and Proinflammatory Cytokines in Cultured Human Keratinocytes", Annals of Dermatology, 26(3), pp.296~302 (2014), 대한피부과학회
- Venugopal PG., "Activation and regulation of toll-like receptors(TLRs)by helminth parasites", Immunol Res, 43, pp.252~263 (2009)
- Schauber J., "Pathogenic DNA : cytosolic DNA promotes inflammation in psoriasis", Cell Cycle, 10, pp.3038~3039 (2011)
- Krueger JG., "Psoriasis pathophysiology: current concepts of pathogenesis", Ann Rheum Dis, 64(Suppl 2), pp.ii30~ii36 (2005)
- Boniface K., "A role for T cell-derived interleukin 22 in psoriatic skin inflammation", Clin Exp Immunol, 150, pp.407~415 (2007)
- Dyring-Andersen B., "CD4(+)T cells producing interleukin(IL)-17, IL-22 and interferon-γ are major effector T cells in nickel allergy", Contact Dermatitis, 68, pp.339~347 (2013)